Pantoprazol Altan (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Altan, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Altan is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: heals erosions and prevents further damage. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - Helicobacter pylori eradication regimens (as adjunct): enhances ulcer healing when used with antibiotics.

Pantoprazol Altan may cause a range of adverse reactions. Most are mild and transient, but serious events can occur rarely.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: watery stools, usually self‑limiting. - Nausea: occasional upset stomach. - Abdominal pain: cramp‑like discomfort. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty. - Clostridioides difficile infection: persistent diarrhoea, abdominal pain. - Low magnesium (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fracture risk: especially with long‑term use. - Liver enzyme elevation: jaundice, dark urine. - Acute interstitial nephritis: kidney inflammation, reduced urine output.

Before prescribing Pantoprazol Altan, clinicians should consider several safety aspects: - Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for interaction with drugs requiring gastric acidity. - Monitor long‑term users: watch for bone density loss and magnesium levels. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Elderly patients: start at the lowest effective dose and monitor for adverse effects. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Pantoprazol Altan can affect the pharmacokinetics of several medicines. Awareness of the interaction potential helps optimise therapy.

Major Interactions (Avoid): - Antifungal agents (e.g., ketoconazole, itraconazole): reduced absorption, loss of efficacy. - HIV protease inhibitors (e.g., atazanavir): markedly decreased plasma levels. - Clopidogrel: diminished antiplatelet effect, increased cardiovascular risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Methotrexate (high dose): reduced renal clearance, watch for toxicity. - Digoxin: slight increase in serum concentration, check levels if clinically indicated.